Comparing the current results to its competitors, Greenbrook Tms Inc reported Revenue increase in the 2 quarter 2024 by 12.85 % year on year, while most of its competitors have experienced contraction in revenues by -1.34 %, achieved in the same quarter.
Greenbrook Tms Inc 's Comment on Competition and Industry Peers
The company operates in a fragmented competitive landscape for TMS treatment, presenting opportunities for consolidation. It offers Spravato® (esketamine nasal spray) therapy and TMS treatment, typically not competing with its referral network. Competitors include other specialist TMS providers and providers of esketamine nasal spray therapy or intravenous ketamine. Indirect competition arises from pharmaceutical and other companies developing anti-depressant medications with advantages such as widespread market acceptance, ease of use, and established reimbursement. The company also competes with providers of invasive neuromodulation therapies, including ECT and VNS. Potential new market entrants may develop alternative treatments that could reduce the competitiveness of the company's products.
Biocorrx Inc is a pharmaceutical company that primarily focuses on providing medication-assisted treatment for substance use disorders. Their business model revolves around the development and commercialization of their proprietary naltrexone implant, coupled with a supportive counseling program. By offering an implant that delivers continuous medication over an extended period, Biocorrx aims to enhance treatment efficacy, reduce relapse rates, and provide a comprehensive solution for individuals struggling with addiction.
American Well Corporation operates as a telehealth platform that connects patients with healthcare providers through video consultations. It partners with health plans, hospitals, and other organizations to offer virtual healthcare services, enabling patients to access affordable and convenient medical care from their homes. The company generates revenue by charging fees for each virtual visit conducted on its platform.
Marpai Inc. operates under a subscription-based business model, providing customers with access to an online platform that offers various educational courses and tutorials. The company generates revenue by charging users a monthly or annual fee for accessing their content, allowing customers to enhance their skillset and gain knowledge in a wide range of subjects. Marpai Inc. retains customers through regular updates and new course offerings, ensuring continued engagement and value for their subscribers.
Sources:
Greenbrook Tms Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Greenbrook Tms Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
